25.08.2016 Views

VACCINE

4Xcr4V9hT

4Xcr4V9hT

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Biologicals • September 2014<br />

Adventitious agents in viral vaccines:<br />

Lessons learned from 4 case studies<br />

Author Information<br />

John Petricciania, Rebecca Sheetsb, Elwyn Griffiths, Ivana Knezevicd<br />

IABS, POB 1925, Palm Springs, CA 92263, USA<br />

Grimalkin Partners, 13401 Norden Drive, Silver Spring, MD 20906, USA<br />

The Farthings, Kingston Upon Thames, Surrey KT2 7PT, UK<br />

Group Lead, Norms and Standards for Biologicals<br />

Department of Essential Medicines and Health Products (EMP)<br />

Health Systems and Innovation (HIS) Cluster<br />

WHO L276, Avenue Appia 20, 1211 Geneva 27, Switzerland<br />

Abstract<br />

Since the earliest days of biological product manufacture, there have been a number<br />

of instances where laboratory studies provided evidence for the presence of adventitious<br />

agents in a marketed product. Lessons learned from such events can be used to<br />

strengthen regulatory preparedness for the future. We have therefore selected four instances<br />

where an adventitious agent, or a signal suggesting the presence of an agent,<br />

was found in a viral vaccine, and have developed a case study for each. The four<br />

cases are: a) SV40 in polio vaccines; b) bacteriophage in measles and polio vaccines;<br />

c) reverse transcriptase in measles and mumps vaccines; and d) porcine circovirus<br />

and porcine circovirus DNA sequences in rotavirus vaccines. The lessons learned<br />

from each event are discussed. Based in part on those experiences, certain scientific<br />

principles have been identified by WHO that should be considered in regulatory risk<br />

evaluation if an adventitious agent is found in a marketed vaccine in the future.<br />

“We have therefore selected four<br />

instances where an adventitious agent,<br />

or a signal suggesting the presence of an<br />

agent, was found in a viral vaccine, and have<br />

developed a case study for each.<br />

The four cases are: a) SV40 in polio vaccines;<br />

b) bacteriophage in measles and polio vaccines;<br />

c) reverse transcriptase in measles<br />

and mumps vaccines; and d) porcine<br />

circovirus and porcine circovirus DNA<br />

sequences in rotavirus vaccines.”<br />

http://www.sciencedirect.com/science/article/pii/S1045105614000748

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!